Clinical Trial

A Study to Evaluate the Effect of BMS-986278 on Cardiac Repolarization in Healthy Participants

Completed Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate the effect of BMS-986278 on the cardiac repolarization in healthy participants.
Protocol Amendment History 1 change
critical Trial completed 2026-08-04
Trial Details
NCT Number NCT07422298
Lead Sponsor Bristol-Myers Squibb
Conditions Healthy Volunteers
Enrollment 32 participants
Start Date 2026-02-19
Primary Completion 2026-06-14 (estimated)
Study Completion 2026-06-14 (estimated)
Updated on ClinicalTrials.gov 2026-08-03